• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环内皮细胞作为异基因造血干细胞移植中内皮损伤的标志物。

Circulating endothelial cells as a marker of endothelial damage in allogeneic hematopoietic stem cell transplantation.

作者信息

Woywodt Alexander, Scheer Johanna, Hambach Lothar, Buchholz Stefanie, Ganser Arnold, Haller Hermann, Hertenstein Bernd, Haubitz Marion

机构信息

Division of Nephrology, Department of Internal Medicine, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany.

出版信息

Blood. 2004 May 1;103(9):3603-5. doi: 10.1182/blood-2003-10-3479. Epub 2004 Jan 8.

DOI:10.1182/blood-2003-10-3479
PMID:14715625
Abstract

Damage to endothelial cells is the common feature of vascular disorders associated with hematopoietic stem cell transplantation (HSCT). Elevated numbers of circulating endothelial cells reflect the extent of endothelial damage in a variety of disorders but their use in HSCT has not been investigated so far. We studied 39 patients undergoing allogeneic HSCT with different conditioning regimens and 22 healthy controls. Circulating endothelial cells were enumerated with immunomagnetic isolation during the course of HSCT. After conditioning, cell numbers were significantly elevated (median 44 cells/mL) compared with baseline (median 16 cells/mL) and controls (median 8 cells/mL). Patients who received radiation had an earlier peak when compared with patients who received chemotherapy. Patients who received reduced-intensity conditioning had significantly lower cell numbers (median 24 cells/mL) than those who received standard conditioning. These observations provide a novel marker to investigate microvascular endothelial damage and the effects of different conditioning regimens in patients undergoing HSCT.

摘要

内皮细胞损伤是与造血干细胞移植(HSCT)相关的血管疾病的共同特征。循环内皮细胞数量的增加反映了多种疾病中内皮损伤的程度,但迄今为止尚未对其在HSCT中的应用进行研究。我们研究了39例接受不同预处理方案的异基因HSCT患者和22名健康对照者。在HSCT过程中,通过免疫磁珠分离法对循环内皮细胞进行计数。预处理后,细胞数量与基线(中位数16个细胞/毫升)和对照者(中位数8个细胞/毫升)相比显著升高(中位数44个细胞/毫升)。与接受化疗的患者相比,接受放疗的患者峰值出现得更早。接受减低强度预处理的患者细胞数量(中位数24个细胞/毫升)明显低于接受标准预处理的患者。这些观察结果为研究接受HSCT患者的微血管内皮损伤以及不同预处理方案的效果提供了一个新的标志物。

相似文献

1
Circulating endothelial cells as a marker of endothelial damage in allogeneic hematopoietic stem cell transplantation.循环内皮细胞作为异基因造血干细胞移植中内皮损伤的标志物。
Blood. 2004 May 1;103(9):3603-5. doi: 10.1182/blood-2003-10-3479. Epub 2004 Jan 8.
2
The release of soluble factors contributing to endothelial activation and damage after hematopoietic stem cell transplantation is not limited to the allogeneic setting and involves several pathogenic mechanisms.造血干细胞移植后促成内皮细胞活化和损伤的可溶性因子释放并不局限于异基因移植情况,且涉及多种致病机制。
Biol Blood Marrow Transplant. 2009 May;15(5):537-46. doi: 10.1016/j.bbmt.2009.01.013.
3
Circulating endothelial cell enumeration demonstrates prolonged endothelial damage in recipients of myeloablative allogeneic stem cell transplantation.循环内皮细胞计数显示,清髓性异基因干细胞移植受者存在持续性内皮损伤。
Haematologica. 2015 Jun;100(6):e246-9. doi: 10.3324/haematol.2014.121731. Epub 2015 Feb 20.
4
Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantation.计算代价:造血干细胞移植中内皮损伤的标志物
Bone Marrow Transplant. 2004 Dec;34(12):1015-23. doi: 10.1038/sj.bmt.1704733.
5
Endothelial dysfunction after hematopoietic stem cell transplantation: role of the conditioning regimen and the type of transplantation.造血干细胞移植后内皮功能障碍:预处理方案和移植类型的作用。
Biol Blood Marrow Transplant. 2010 Jul;16(7):985-93. doi: 10.1016/j.bbmt.2010.02.008. Epub 2010 Feb 16.
6
Level of vascular endothelial growth factor predicts both relapse and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation.血管内皮生长因子水平可预测异基因造血干细胞移植后的复发和非复发死亡率。
Biol Blood Marrow Transplant. 2013 Dec;19(12):1677-82. doi: 10.1016/j.bbmt.2013.08.015. Epub 2013 Sep 10.
7
Predictive value of circulating angiopoietin-2 for endothelial damage-related complications in allogeneic hematopoietic stem cell transplantation.循环血管生成素-2对异基因造血干细胞移植中内皮损伤相关并发症的预测价值。
Biol Blood Marrow Transplant. 2014 Sep;20(9):1335-40. doi: 10.1016/j.bbmt.2014.04.030. Epub 2014 May 2.
8
Circulating endothelial cell count: a reliable marker of endothelial damage in patients undergoing hematopoietic stem cell transplantation.循环内皮细胞计数:造血干细胞移植患者内皮损伤的可靠标志物。
Bone Marrow Transplant. 2017 Dec;52(12):1637-1642. doi: 10.1038/bmt.2017.194. Epub 2017 Sep 11.
9
Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning.与清髓性预处理相比,减低剂量预处理的异基因造血干细胞移植中闭塞性细支气管炎的发生率较低。
Bone Marrow Transplant. 2005 Jun;35(12):1195-200. doi: 10.1038/sj.bmt.1704985.
10
The gut mucosa barrier is preserved during allogeneic, haemopoietic stem cell transplantation with reduced intensity conditioning.在采用减低剂量预处理的异基因造血干细胞移植过程中,肠道黏膜屏障得以保留。
Bone Marrow Transplant. 2001 Oct;28(8):737-42. doi: 10.1038/sj.bmt.1703230.

引用本文的文献

1
Neurological involvement in hematopoietic stem cell transplantation-associated thrombotic microangiopathy.造血干细胞移植相关性血栓性微血管病的神经学表现。
Ann Hematol. 2024 Sep;103(9):3303-3313. doi: 10.1007/s00277-024-05798-6. Epub 2024 May 20.
2
Metformin pretreatment ameliorates busulfan-induced liver endothelial toxicity during haematopoietic stem cell transplantation.二甲双胍预处理可改善造血干细胞移植期间白消安引起的肝内皮毒性。
PLoS One. 2023 Oct 26;18(10):e0293311. doi: 10.1371/journal.pone.0293311. eCollection 2023.
3
Rapid cardiovascular aging following allogeneic hematopoietic cell transplantation for hematological malignancy.
血液系统恶性肿瘤异基因造血细胞移植后心血管快速衰老
Front Cardiovasc Med. 2022 Dec 15;9:926064. doi: 10.3389/fcvm.2022.926064. eCollection 2022.
4
Circulating Endothelial Cells: A New Possible Marker of Endothelial Damage in Kawasaki Disease, Multisystem Inflammatory Syndrome in Children and Acute SARS-CoV-2 Infection.循环内皮细胞:川崎病、儿童多系统炎症综合征和急性 SARS-CoV-2 感染中内皮损伤的新的可能标志物。
Int J Mol Sci. 2022 Sep 3;23(17):10106. doi: 10.3390/ijms231710106.
5
Circulating endothelial cells and the study of vascular injury in children undergoing hematopoietic stem cell transplant.循环内皮细胞与接受造血干细胞移植儿童的血管损伤研究
Haematologica. 2022 Dec 1;107(12):2950-2954. doi: 10.3324/haematol.2022.280788.
6
Thromboinflammation in Myeloproliferative Neoplasms (MPN)-A Puzzle Still to Be Solved.骨髓增殖性肿瘤(MPN)中的血栓炎症——一个待解决的难题。
Int J Mol Sci. 2022 Mar 16;23(6):3206. doi: 10.3390/ijms23063206.
7
Biomarkers of graft--host disease: Understanding and applications for the future.移植物抗宿主病的生物标志物:对未来的理解与应用
World J Transplant. 2021 Aug 18;11(8):335-343. doi: 10.5500/wjt.v11.i8.335.
8
The possible role of mutated endothelial cells in myeloproliferative neoplasms.突变内皮细胞在骨髓增殖性肿瘤中的可能作用。
Haematologica. 2021 Nov 1;106(11):2813-2823. doi: 10.3324/haematol.2021.278499.
9
Biomarkers for Early Complications of Endothelial Origin After Allogeneic Hematopoietic Stem Cell Transplantation: Do They Have a Potential Clinical Role?同种异体造血干细胞移植后内皮起源早期并发症的生物标志物:它们具有潜在的临床作用吗?
Front Immunol. 2021 May 19;12:641427. doi: 10.3389/fimmu.2021.641427. eCollection 2021.
10
Prognostic plasma biomarkers of early complications and graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植患者早期并发症和移植物抗宿主病的预后血浆生物标志物
EJHaem. 2020 Jul;1(1):219-229. doi: 10.1002/jha2.26. Epub 2020 Jun 17.